References
- Cutolo M, Sulli A, Smith V. Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol 2010;6:578-587. https://doi.org/10.1038/nrrheum.2010.104
- Pathak R, Gabor AJ. Scleroderma and central nervous system vasculitis. Stroke 1991;22:410-413. https://doi.org/10.1161/01.STR.22.3.410
- Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease: disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969;20:288-299. https://doi.org/10.1001/archneur.1969.00480090076012
- Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med 2009;360:1226-1237. https://doi.org/10.1056/NEJMra0804622
- Cheng KS, Tiwari A, Boutin A, et al. Carotid and femoral arterial wall mechanics in scleroderma. Rheumatology (Oxford) 2003;42:1299-1305. https://doi.org/10.1093/rheumatology/keg371
- Sherer Y, Cerinic MM, Bartoli F, et al. Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosis. Ann N Y Acad Sci 2007;1108:259-267. https://doi.org/10.1196/annals.1422.028
- Terajima K, Shimohata T, Watanabe M, et al. Cerebral vasculopathy showing moyamoya-like changes in a patient with CREST syndrome. Eur Neurol 2001;46:163-165. https://doi.org/10.1159/000050795